Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Https://m.youtube.com/watch?v=ZqhxdcPgjHw
I was reviewing old stuff from MHCs updates and investor meetings etc.
This one last year was so interesting for many reasons.
The fact it proceeded a time when the first six months had seen such low revenue and MHC was streaming the costs to ensure they had sufficient cash reserves.
Since then they have had a further 7 months of solid sales bringing in huge revenue streams.
Back to to investors meeting.
1, I note our Chairman stated they would be putting out forward sales projections for the new products by end of year or next year meaning early 2024.
So I hope he’s in a position to update us shortly!.
2, Penny was extremely confident in phlebotomy department and almost emphasised the fact that they were trialing things that need to be financially beneficial to the NHS. The fact she also almost certainly eluded to Boots in store testing facility and the digital data along with the WIH achievement gives me 100% confidence that we should expect Ann announcement that certain Tests will be available to NHS referred patients direct to Boots Hubs.
I would say given the increased revenue from June last year this has been essential to driving to expansion more rapidly.
3, Penny also ruled out acquisitions but focused on partnerships. She also said the wellbeing market will see smaller companies fail or get adsorbed!.
4, I wonder if the board are aware of price sensitive information which may be why they haven’t purchased cheap stock. Adam did say whilst they had cash acquisitions would usually be funded by a higher share price to raise equity so they clearly would have no interest unless price rose significantly.
5, it’s clear the new products are being sold more each day but they also mentioned the 801 stores selling tests in store. Would be interesting to note if these stores also have the boots in store testing facilities.
I believe the answer would be yes.
I think given Adam Reynolds comments we should assume a RNS with guidance on new tests be published to the market to ensure credibility is in tact. This could be a game changer.
I also believe they are selling off the 5pks to ensure old stock is sold before bringing in new 25pks.
I think the share price needs these figures before we see a significant run up on the price. Until then we may just range trade so I hope it soon as nearly 9 months data available on new tests sales.
It would be an ideal time for Penny to start doing some media presentations or at least let’s see some social media influencers as alerted to in August update.
The recent tick up in price would keep heading up if the market is given a RNS or VC something.
Do we really want it to drift back!
I certainly don’t but everything needs something to fuel it.
Come on Penny it’s a reasonable request to appease LTH
Https://onlinedoctor.boots.com/home-testing-kits?utm_source=Boots&utm_medium=referral&utm_campaign=Boots_testing_kits
With the heavy investment in digital data and test on the shelves in Boots I wonder how long before we announce a new collaboration between Boots, the NHS Doctors and GPs and MHC tests in stores where appropriate.
There must be a reason for only 801 selected for initial roll out.
Is the a monitoring exercise!
Will this develop into a wider arrangement!.
Seams very plausible given the savings on NHS resources
Https://www.google.com/search?q=what+does+it+cost+the+NHS+for+each+patient+that+has+a+blood+test&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari
The average standard blood test costs the NHS £10.00
To get GP appointment takes days or weeks depending on postcode usually!!.
Then the referral etc and costs to nurse etc.
Time taken up in hospitals if your referred.
Then usually another trip back to GP for results.
Surely MHC are aware of the process and costs and see the future in wellness and wellbeing.
MHC could be onto a real winner with Boots if they expand the service.
The time and money and hours freed up for NHS professionals would take a huge strain off the NHS.
The chairman’s statement in August mentions the NHS so I’m sure they are working on something.
This is also by the emphasis on phlebotomy testing and need to comply with standards to meet HIW.
I hope Penny realises private tests is a winner but also providing a service to the NHS would send revenue to another level.
Paul
The thing is we had a pandemic as a result of Chinese lack of ability to control it.
The fact is many initial covid companies have gone bust or been swallowed up.
MHC was always going to be a wellbeing company and made it clear Covid was a means to help it on the journey.
The journey has been a painful one 100% because market sentiment has changed due to inflation and a war in Europe!.
The facts are we have emerged stronger from the pandemic and truly established our footing in the sector. We are financially solid and self sufficient. No investor dilution and cash rich in many ways.
Fixtures and fittings in 801 stores fully paid. Products fully paid and digital data growing.
We met HIW standards and in a position to truly expand things.
There’s certainly risk as in all AIM companies but is it on the right track and have the board been prudent or waist full. I’d say Penny has been exceptional and prudent and steering us through difficult macroeconomic times and we could be one of the tru growth stories if we survive independently without a takeover from arrivals.
If one bought in the height of the pandemic why wouldn’t you buy at a 90% discount and in a stronger position with actual products now seeing traction.
I would like to see Directors buy buying but that’s personal choice.
It will be bumpy as Covid Revenue has peaks and troughs but we must believe true revenue from new products can slowly be extracted.
'Covid and lockdown has changed the game'
should we have them more often??
Https://m.youtube.com/watch?v=w4nwU-mB9EY&pp=ygUKY292aWQgbmV3cw%3D%3D
Whatever happens we must realise COVID revenue has seriously helped investors value in the longer term. Short term we all feel the share price is way to low but I’m sure it will eventually rise but we 100% could do with positive news as regards new product sales.
Once the market sees a clear strategy it will attract larger buyers but as I’ve stated before only 52 shares in circulation and many of them tied up.
Good news would create a squeeze. The recent fall was on very little shares sold .
It would be nice for a steady rise in my opinion.
I didn’t realise that the majority of the higher priced tests were available in store. I just checked a few of them (not that I doubted you) and all showing in stores near me … e.g. Thyroid profile £45, Weight Management £54. Very good news. So the Covid tests bring in the revenues and small profits, but steady. In the meantime allows time for wellness tests to grow reach. Another national channel please …
Amber
Based on average 3 tests sold in each store combined between 5pk and single ones sold in average 2500 stores between Boots and Lloyds and average daily sales on I would say the month of January will be closer to 1m revenue.
What excites me is the fact the new product are also being sold in 801 stores. We have also paid for all the racking in the stores so the real growth is getting traction in footfall in stores.
We then have an option to expand into many more stores if demand warrants it.
I 100 believe a deal allowing us to work with Boots to complete immediate testing in established booths already in place which could open the doors for patients being sent to use our facilities. The fact we have everything in place and meet necessary requirements.
I know they have continued to state the strategy is private testing I’m sure Penny is aware this would be explosive stuff.
After all she was smart enough to move in LFT from PCR which has enabled growth with dilution to share holders.
All possibilities at the moment but don’t rule anything out. Even a takeover
FlowFlex £8.49 bundle + 100 sales consistently daily for past couple of months and will continue Jan/Feb - over £1m rev p/m on Covid sales? Not a fact - a question?
FlowFlex £49 bundle out of stock again - good sign or bad logistics?
+70 wellness kits sold past 24 hours = 20 stomach ulcer, Iron 18, Thyroid 11, Sperm 6, Vit D 11
All above products available in high st stores - I dont know how many tbh
4* and above reviews for majority of wellness tests
NHS under huge strain and it wont get better
TrustPilot rating 4.4 (Excellent) with over 7k reviews
Latest reviews show many relate to wellness tests
The word "traction" was used in the latest update. Now this is very subjective, however looking at the sales online (albeit they are small in the grand scheme of things) they are starting to pick up and not just the
Covid and lockdown has changed the game
It is a competitive industry with not many consumers and still the populace will spend their money on a pizza or kebab before they consider their health. Just look how many billions the take away industry is worth compared to this!
Can some one do a calculation of how much Revenue we would make if 801 stores sold just 1 test in each range each day for 52 weeks!.
Well I tell you the intolerance test would be over 15m alone at just 1 test per day for 52 weeks in 801 stores.
Then we have online sales.
So we can see the potential for growth is truly incredible.
I do fully see MHC going out for growth in the new products in 2024.
It will be driven by a up beat guidance in sales in new products.
Https://www.boots.com/myhealthchecked-intolerances-sensitivities-dnatest-10322824
So 9 sold in the last 24 hrs at £54.00 each
Some say that’s nothing.
They are in 801 stores along with the other new lines.
801 x 4 tests x 7 days a week x 52 week X £54.00 each =
How many millions!!!!!
Online these weren’t selling a month ago and now we can see what traction means.
Online is a guide but instore is the growth potential.
Nearly 2000 Boots nationwide!
If your short term then it’s not for you but medium to long term holders understand the potential.
People are sick of the NHS.
I see this exploding but i believe in the strategy and don’t mind pull backs
The potential to ramp this up to another level is clear to see. I just just hope MHC can handle it.
Then imagine if NHS get approved to get tests on the NHS and use the facilities in Boots to get the tests same day.
MHC are meeting all the guidelines to allow this.
Do people really believe Penny hasn’t thought it through.
Paul your previous comment had nothing to do with this company, what an odd thing to say. Why don't you go message ford about how bad your BMW is 🤣🤣
You won’t get figures as regards new products until March.
Don’t really see a panic.
MHC just need to keep producing decent figures and leave the rest upto the market and see when sentiment changes.
Many companies on the AIM with no revenue however much greater valuation.
They need to keep diluting to stay afloat so I’m comfortable with MHC financially by equally disappointed with share price like most investors
@vinnie.
‘ No figures on new products, no news, no positivity, no explanation of delay in RNS. Woeful PR management’
How deep are your losses?
Paul1deano
What does that have to do with Mhc?
Ok I did tests with another provider of these services and got my results back advising me to go and see my doctor, they sent me for their tests and it came back within tolerance as the testing equipment they use is to of a higher standard.
Think of an oxi meter you buy for £20 or £30 which shows levels below 92% then the paramedics turn up with a couple of thousand pound machine and it is normal.
As for Dr John Campbell, who I have been told is not a medical Doctor but has a doctorate in nursing unless I can be corrected. I don’t take his advice to be honest.
Not an investor here, but I’m definitely thinking about it after using a My Health Checked lateral flow test yesterday to check my vitamin D blood levels. After all Dr John Campbell’s videos on this, I’m sure many people will be buying these affordable and easy to use kits. I bought the last two test packs available from my local Boots yesterday, and today I will buy more of these tests for family from Amazon.
GLA, I think you could be onto a winner here!
I can’t remember the last time I posted on here.
However I still see covidiots are still believing and hiding behind the sofa.
Some people are short term traders and others are long term.
I’m long term and happy to top up on pull backs so I take it I’m presented with a top up opportunity.
We will see how this turns out but I’m also disappointed with the pullback as I truly felt we had decent results and with such a low PE I hope we can move upwards soon enough when the few sellers from the 52 m shares are done.
Maybe Donald has another order he’s filling up lol.
Good luck and lose sleep as I’m certainly not and truly trust in Penny
SeedyG
You could be correct but my interpretation of ramping is putting up stuff without foundation. However I’m definitely fully loyal in my support for MHC.
Just over 400,000 shares sold from 52 million and you insinuate it’s ramping.
I don’t think our Donald who bought 1.5m million calls it ramping.lol
Some people are short m
Judging by the number of sells, not many investors seem impressed by your ramping Jamrock
The human race is finished. Might be disease. Might be war. Probably global warming. Fortunately I no longer worry. What will be will be. Super day here so off for a walk along the seashore. Be good..